Publication
Title
Epidermal Growth Factor Receptor (EGFR) pathway biomarkers in the randomized phase III trial of erlotinib versus observation in ovarian cancer patients with no evidence of disease progression after first-line platinum-based chemotherapy
Author
Institution/Organisation
European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG)
Abstract
Language
English
Source (journal)
Targeted oncology. - Paris
Publication
Paris : 2015
ISSN
1776-2596
Volume/pages
10:4(2015), p. 583-596
ISI
000365770300013
Full text (Publisher's DOI)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
External links
Web of Science
Record
Identification
Creation 18.04.2016
Last edited 19.04.2018
To cite this reference